Download the press release here
Download the press release here Download PDFWe have entered into a definitive agreement to sell our Infant Formula and Child Nutrition (IFCN) business in China1 to Primavera Capital Group (“Primavera”).
The outcome is the result of a comprehensive strategic review and is in line with our strategy to actively manage our portfolio as part of our plan to rejuvenate sustainable growth.
1 China, Hong Kong and Taiwan